Corbus Pharmaceuticals Holdings, Inc. CRBP
$3.87
-1.15%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $39.71
- Implied Upside
- +926.2%
- Price Target Range
- $30.00 – $53.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-14 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $35 |
| 2026-08-07 | OppenheimerJeff Jones |
Maintains | Outperform | $52 → $48 |
| 2026-08-07 | HC Wainwright & Co.Andres Y. Maldonado |
Maintains | Buy | $40 → $35 |
| 2026-06-23 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $44 → $34 |
| 2026-06-17 | OppenheimerJeff Jones |
Maintains | Outperform | $54 → $52 |
| 2026-05-27 | WedbushRobert Driscoll |
Maintains | Outperform | $38 → $30 |
| 2026-05-26 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $40 |
| 2026-05-22 | MizuhoGraig Suvannavejh |
Maintains | Outperform | $40 → $44 |
| 2026-05-13 | JefferiesMaury Raycroft |
Maintains | Buy | $36 → $33 |
| 2026-05-13 | OppenheimerJeff Jones |
Maintains | Outperform | $57 → $54 |
| 2026-05-13 | GuggenheimPaul Jeng |
Reiterates | Buy | $45 |
| 2026-04-29 | GuggenheimPaul Jeng |
Initiates coverage on | Buy | $45 |
| 2026-03-10 | OppenheimerJeff Jones |
Maintains | Outperform | $53 → $57 |
| 2025-11-13 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $55 → $53 |
| 2025-10-20 | WedbushRobert Driscoll |
Maintains | Outperform | $31 → $38 |
| 2025-10-20 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $40 |
| 2025-09-17 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $40 |
| 2025-08-06 | OppenheimerJeff Jones |
Maintains | Outperform | $56 → $53 |
| 2025-05-07 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $65 → $58 |
| 2025-05-07 | OppenheimerJeff Jones |
Maintains | Outperform | $60 → $56 |
| 2025-05-07 | HC Wainwright & Co.Andres Maldonado |
Maintains | Buy | $50 → $40 |
| 2025-03-12 | HC Wainwright & Co.Andres Maldonado |
Reiterates | Buy | $75 → $50 |
| 2025-03-11 | JefferiesMaury Raycroft |
Maintains | Buy | $70 → $53 |
| 2025-02-28 | William BlairAndy Hsieh |
Initiates coverage on | Outperform | — |
| 2025-02-18 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $75 |
| 2025-02-10 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $80 → $75 |
| 2024-12-02 | Piper SandlerBiren Amin |
Initiates coverage on | Overweight | $35 |
| 2024-09-23 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $80 |
| 2024-09-20 | B. Riley SecuritiesKalpit Patel |
Maintains | Buy | $85 → $40 |
| 2024-09-20 | WedbushRobert Driscoll |
Maintains | Outperform | $85 → $51 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.87
- Market Cap
- $75.72 million
- 52-Week Range
- $3.73 – $20.56
- Average Volume
- 1.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.